IL161946A0 - Urea substituted imidazopyridines - Google Patents

Urea substituted imidazopyridines

Info

Publication number: IL161946A0
Authority: IL; Israel
Prior art keywords: urea substituted; substituted imidazopyridines; imidazopyridines; urea; substituted
Prior art date: 2001-12-06

Application number

IL16194602A

Other languages

English (en)

Original Assignee

3M Innovative Properties Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-06

Filing date

2002-06-07

Publication date

2005-11-20

2002-06-07 Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co

2005-11-20 Publication of IL161946A0 publication Critical patent/IL161946A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Hematology (AREA)
Tropical Medicine & Parasitology (AREA)
Biotechnology (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
AIDS & HIV (AREA)
Gastroenterology & Hepatology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL16194602A 2001-12-06 2002-06-07 Urea substituted imidazopyridines IL161946A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/016,073 US20020107262A1 (en)	2000-12-08	2001-12-06	Substituted imidazopyridines
PCT/US2002/018284 WO2003050119A2 (en)	2001-12-06	2002-06-07	Urea substituted imidazopyridines

Publications (1)

Publication Number	Publication Date
IL161946A0 true IL161946A0 (en)	2005-11-20

Family

ID=21775232

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IL16178702A IL161787A0 (en)	2001-12-06	2002-06-07	Sulfonamido substituted imidazopyridines
IL16194502A IL161945A0 (en)	2001-12-06	2002-06-07	Amide substituted imidazopyridines
IL16194602A IL161946A0 (en)	2001-12-06	2002-06-07	Urea substituted imidazopyridines

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
IL16178702A IL161787A0 (en)	2001-12-06	2002-06-07	Sulfonamido substituted imidazopyridines
IL16194502A IL161945A0 (en)	2001-12-06	2002-06-07	Amide substituted imidazopyridines

Country Status (18)

Country	Link
US (1)	US20020107262A1 (xx)
EP (3)	EP1453829A1 (xx)
JP (3)	JP2005513052A (xx)
KR (3)	KR20040105696A (xx)
CN (4)	CN100402528C (xx)
AU (3)	AU2002315006B2 (xx)
BR (3)	BR0214752A (xx)
CA (3)	CA2468659A1 (xx)
HR (3)	HRP20040503A2 (xx)
IL (3)	IL161787A0 (xx)
MX (3)	MXPA04005363A (xx)
NO (3)	NO20042621L (xx)
NZ (3)	NZ532770A (xx)
PL (3)	PL374260A1 (xx)
RU (3)	RU2004117156A (xx)
UA (3)	UA77709C2 (xx)
WO (3)	WO2003050119A2 (xx)
ZA (3)	ZA200405336B (xx)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003103584A2 (en)	2002-06-07	2003-12-18	3M Innovative Properties Company	Ether substituted imidazopyridines
AU2004205642C1 (en)	2003-01-14	2012-01-12	Arena Pharmaceuticals, Inc.	1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US20040265351A1 (en)	2003-04-10	2004-12-30	Miller Richard L.	Methods and compositions for enhancing immune response
US20040202720A1 (en) *	2003-04-10	2004-10-14	3M Innovative Properties Company	Delivery of immune response modifier compounds using metal-containing particulate support materials
AR045047A1 (es)	2003-07-11	2005-10-12	Arena Pharm Inc	Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
TW200510412A (en) *	2003-08-12	2005-03-16	3M Innovative Properties Co	Oxime substituted imidazo-containing compounds
EP2939693A1 (en) *	2003-08-14	2015-11-04	3M Innovative Properties Company	Lipid-modified immune response modifiers
AR045529A1 (es)	2003-08-27	2005-11-02	3M Innovative Properties Co	Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi
CA2537763A1 (en)	2003-09-05	2005-03-17	3M Innovative Properties Company	Treatment for cd5+ b cell lymphoma
KR101494056B1 (ko)	2003-10-03	2015-02-16	쓰리엠 이노베이티브 프로퍼티즈 컴파니	피라졸로피리딘 및 그의 유사체
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
WO2005032484A2 (en)	2003-10-03	2005-04-14	3M Innovative Properties Company	Alkoxy substituted imidazoquinolines
WO2005037791A1 (en) *	2003-10-15	2005-04-28	Chiron Corporation	Compositions and methods for viral inhibition
JP2007511527A (ja) *	2003-11-14	2007-05-10	スリーエムイノベイティブプロパティズカンパニー	オキシム置換イミダゾ環化合物
EP1682544A4 (en)	2003-11-14	2009-05-06	3M Innovative Properties Co	HYDROXYLAMINE SUBSTITUTED IMIDAZO RING COMPOUNDS
JP2007512349A (ja) *	2003-11-25	2007-05-17	スリーエムイノベイティブプロパティズカンパニー	ヒドロキシルアミンおよびオキシム置換した、イミダゾキノリン、イミダゾピリジン、およびイミダゾナフチリジン
AU2004293078B2 (en)	2003-11-25	2012-01-19	3M Innovative Properties Company	Substituted imidazo ring systems and methods
EP1694674A4 (en) *	2003-12-04	2010-07-07	3M Innovative Properties Co	IMIDAZO CYCLIC ETHERS SUBSTITUTED WITH SULFONE
US8802853B2 (en)	2003-12-29	2014-08-12	3M Innovative Properties Company	Arylalkenyl and arylalkynyl substituted imidazoquinolines
US7888349B2 (en) *	2003-12-29	2011-02-15	3M Innovative Properties Company	Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds
EP1699788A2 (en)	2003-12-30	2006-09-13	3M Innovative Properties Company	Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
EP1730143A2 (en)	2004-03-24	2006-12-13	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123079A2 (en) *	2004-06-14	2005-12-29	3M Innovative Properties Company	Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en)	2004-06-15	2011-09-13	3M Innovative Properties Company	Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
JP5128940B2 (ja) *	2004-06-18	2013-01-23	スリーエムイノベイティブプロパティズカンパニー	置換イミダゾキノリン、イミダゾピリジン、およびイミダゾナフチリジン
US8541438B2 (en)	2004-06-18	2013-09-24	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
US8026366B2 (en)	2004-06-18	2011-09-27	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006065280A2 (en)	2004-06-18	2006-06-22	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US7897609B2 (en)	2004-06-18	2011-03-01	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
ATE555786T1 (de) *	2004-09-02	2012-05-15	3M Innovative Properties Co	1-alkoxy 1h-imidazo-ringsysteme und verfahren
CA2578975A1 (en)	2004-09-02	2006-03-16	3M Innovative Properties Company	2-amino 1h imidazo ring systems and methods
EP1804583A4 (en) *	2004-10-08	2009-05-20	3M Innovative Properties Co	ADJUVANT FOR DNA VACCINE
WO2006083440A2 (en)	2004-12-30	2006-08-10	3M Innovative Properties Company	Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
WO2006071997A2 (en) *	2004-12-30	2006-07-06	3M Innovative Properties Company	Treatment for cutaneous metastases
AR052447A1 (es) *	2004-12-30	2007-03-21	3M Innovative Properties Co	Etansulfonato de 1-(2-metipropil)-1h-imidazo[4,5-c] [1,5] naftiridin-4- amina y metansulfonato de 1-(2- metipropil)-1h-imidazo[4,5 -c] [1,5] naftiridin-4-amina
AU2005322898B2 (en)	2004-12-30	2011-11-24	3M Innovative Properties Company	Chiral fused (1,2)imidazo(4,5-c) ring compounds
US8436176B2 (en) *	2004-12-30	2013-05-07	Medicis Pharmaceutical Corporation	Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
WO2006084251A2 (en)	2005-02-04	2006-08-10	Coley Pharmaceutical Group, Inc.	Aqueous gel formulations containing immune reponse modifiers
AU2006212765B2 (en)	2005-02-09	2012-02-02	3M Innovative Properties Company	Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
AU2006338521A1 (en)	2005-02-09	2007-10-11	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods
US7968563B2 (en)	2005-02-11	2011-06-28	3M Innovative Properties Company	Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US8658666B2 (en)	2005-02-11	2014-02-25	3M Innovative Properties Company	Substituted imidazoquinolines and imidazonaphthyridines
WO2006098852A2 (en)	2005-02-23	2006-09-21	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazoquinolines
AU2006216798A1 (en)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazoquinoline compounds and methods
WO2006091568A2 (en)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazonaphthyridines
EP1850849A2 (en)	2005-02-23	2007-11-07	Coley Pharmaceutical Group, Inc.	Method of preferentially inducing the biosynthesis of interferon
WO2006107853A2 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	Pyrazolopyridine-1,4-diamines and analogs thereof
CA2602590A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
CA2605808A1 (en) *	2005-04-25	2006-11-02	3M Innovative Properties Company	Immunostimulatory compositions
ZA200803029B (en)	2005-09-09	2009-02-25	Coley Pharm Group Inc	Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
CN101300254A (zh)	2005-09-09	2008-11-05	科利制药集团公司	N－{2－[4－氨基－2－(乙氧基甲基)－1H－咪唑并[4,5－c]喹啉－1－基]－1,1－二甲基乙基}甲磺酰胺的酰胺和氨基甲酸酯衍生物和方法
CN100344325C (zh) *	2005-10-17	2007-10-24	华南师范大学	一种治疗宫颈癌的药物及其制备方法与应用
KR20080083270A (ko)	2005-11-04	2008-09-17	콜레이 파마시티컬 그룹, 인코포레이티드	하이드록시 및 알콕시 치환된 1에이치 이미다조퀴놀린 및방법
EP3085373A1 (en)	2006-02-22	2016-10-26	3M Innovative Properties Company	Immune response modifier conjugates
WO2007106854A2 (en)	2006-03-15	2007-09-20	Coley Pharmaceutical Group, Inc.	Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods
US7906506B2 (en)	2006-07-12	2011-03-15	3M Innovative Properties Company	Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
JP2010501491A (ja) *	2006-08-24	2010-01-21	オーストラリアンヌークリアサイエンスアンドテクノロジーオーガニゼイション	末梢性ベンゾジアゼピン受容体をターゲッティングするためのフッ化リガンド
WO2008030511A2 (en)	2006-09-06	2008-03-13	Coley Pharmaceuticial Group, Inc.	Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes
GB0625827D0 (en) *	2006-12-22	2007-02-07	Astex Therapeutics Ltd	New compounds
PL2121687T3 (pl)	2006-12-22	2016-03-31	Astex Therapeutics Ltd	Pochodne amin tricyklicznych jako inhibitory białkowej kinazy tyrozynowej
JP5442448B2 (ja)	2006-12-22	2014-03-12	アステックス、セラピューティックス、リミテッド	Ｆｇｆｒインヒビターとしての二環式ヘテロ環式化合物
US20080149123A1 (en)	2006-12-22	2008-06-26	Mckay William D	Particulate material dispensing hairbrush with combination bristles
GB0720038D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New compounds
GB0720041D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New Compounds
CN101239978A (zh) *	2008-03-05	2008-08-13	南方医科大学	一种咪唑并吡啶类化合物
GB0810902D0 (en)	2008-06-13	2008-07-23	Astex Therapeutics Ltd	New compounds
GB0906472D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
GB0906470D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
CN102811998B (zh) *	2009-12-21	2016-03-30	国家健康与医学研究院（Inserm）	新的亲环素抑制剂及其用途
SI2606047T1 (sl)	2010-08-17	2017-04-26	3M Innovative Properties Company	Lipidirani sestavki spojine, ki modificira imunski odgovor, formulacije in postopki
CA2812061A1 (en)	2010-09-22	2012-03-29	Arena Pharmaceuticals, Inc.	Modulators of the gpr119 receptor and the treatment of disorders related thereto
EP2717919B1 (en)	2011-06-03	2016-08-03	3M Innovative Properties Company	Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
JP6415979B2 (ja)	2011-06-03	2018-10-31	スリーエムイノベイティブプロパティズカンパニー	ヒドラジノ１ｈ−イミダゾキノリン−４−アミン及びこれから調製された複合体
WO2015023958A1 (en) *	2013-08-15	2015-02-19	The University Of Kansas	Toll-like receptor agonists
MX386419B (es)	2015-01-06	2025-03-18	Arena Pharm Inc	Metodos de condiciones de tratamiento relacionadas con el receptor s1p1.
MA42807A (fr)	2015-06-22	2018-07-25	Arena Pharm Inc	Sel l-arginine cristallin d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclo-penta[b]indol-3-yl)acétique (composé 1) pour une utilisation dans des troubles associés au récepteur de s1p1
WO2018107173A1 (en) *	2016-12-09	2018-06-14	Vanderbilt University	Glutamine transport inhibitors and methods for treating cancer
KR20190116416A (ko)	2017-02-16	2019-10-14	아레나 파마슈티칼스, 인크.	원발 담즙성 담관염을 치료하기 위한 화합물 및 방법
WO2019123178A1 (en)	2017-12-20	2019-06-27	3M Innovative Properties Company	Amide substitued imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier
KR102859841B1 (ko)	2018-06-06	2025-09-12	아레나 파마슈티칼스, 인크.	S1p1 수용체와 관련된 병태의 치료 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2149276T3 (es) *	1993-07-15	2000-11-01	Minnesota Mining & Mfg	Imidazo(4,5-c)piridin-4-aminas.
ES2290969T3 (es) *	1996-10-25	2008-02-16	Minnesota Mining And Manufacturing Company	Compuestos modificadores de la respuesta inmune para el tratamiento de enfermedades mediadas por th2 y relacionadas.
US6451810B1 (en) *	1999-06-10	2002-09-17	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6331539B1 (en) *	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6541485B1 (en) *	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6376669B1 (en) *	1999-11-05	2002-04-23	3M Innovative Properties Company	Dye labeled imidazoquinoline compounds
UA74593C2 (en) *	2000-12-08	2006-01-16	3M Innovative Properties Co	Substituted imidazopyridines

2001
- 2001-12-06 US US10/016,073 patent/US20020107262A1/en not_active Abandoned
2002
- 2002-06-07 NZ NZ532770A patent/NZ532770A/en unknown
- 2002-06-07 HR HRP20040503 patent/HRP20040503A2/hr not_active Application Discontinuation
- 2002-06-07 JP JP2003551141A patent/JP2005513052A/ja active Pending
- 2002-06-07 MX MXPA04005363A patent/MXPA04005363A/es unknown
- 2002-06-07 CN CNB028242858A patent/CN100402528C/zh not_active Expired - Fee Related
- 2002-06-07 RU RU2004117156/04A patent/RU2004117156A/ru not_active Application Discontinuation
- 2002-06-07 PL PL02374260A patent/PL374260A1/xx not_active Application Discontinuation
- 2002-06-07 AU AU2002315006A patent/AU2002315006B2/en not_active Expired - Fee Related
- 2002-06-07 IL IL16178702A patent/IL161787A0/xx unknown
- 2002-06-07 WO PCT/US2002/018284 patent/WO2003050119A2/en not_active Ceased
- 2002-06-07 WO PCT/US2002/018220 patent/WO2003050117A1/en not_active Ceased
- 2002-06-07 CA CA002468659A patent/CA2468659A1/en not_active Abandoned
- 2002-06-07 AU AU2002312414A patent/AU2002312414B2/en not_active Expired - Fee Related
- 2002-06-07 KR KR10-2004-7008686A patent/KR20040105696A/ko not_active Ceased
- 2002-06-07 JP JP2003551143A patent/JP2005511746A/ja active Pending
- 2002-06-07 MX MXPA04005412A patent/MXPA04005412A/es not_active Application Discontinuation
- 2002-06-07 CA CA002468164A patent/CA2468164A1/en not_active Abandoned
- 2002-06-07 RU RU2004117161/04A patent/RU2004117161A/ru not_active Application Discontinuation
- 2002-06-07 CA CA002468174A patent/CA2468174A1/en not_active Abandoned
- 2002-06-07 RU RU2004117159/04A patent/RU2004117159A/ru not_active Application Discontinuation
- 2002-06-07 CN CNA2008100030374A patent/CN101220028A/zh active Pending
- 2002-06-07 BR BR0214752-1A patent/BR0214752A/pt not_active IP Right Cessation
- 2002-06-07 EP EP02739783A patent/EP1453829A1/en not_active Withdrawn
- 2002-06-07 NZ NZ532927A patent/NZ532927A/en unknown
- 2002-06-07 KR KR10-2004-7008644A patent/KR20040105694A/ko not_active Ceased
- 2002-06-07 PL PL02370702A patent/PL370702A1/xx not_active Application Discontinuation
- 2002-06-07 WO PCT/US2002/018282 patent/WO2003050118A1/en not_active Ceased
- 2002-06-07 HR HRP20040506 patent/HRP20040506A2/hr not_active Application Discontinuation
- 2002-06-07 KR KR10-2004-7008676A patent/KR20040105695A/ko not_active Ceased
- 2002-06-07 HR HRP20040504 patent/HRP20040504A2/hr not_active Application Discontinuation
- 2002-06-07 AU AU2002345615A patent/AU2002345615B2/en not_active Expired - Fee Related
- 2002-06-07 EP EP02741939A patent/EP1451186A2/en not_active Withdrawn
- 2002-06-07 IL IL16194502A patent/IL161945A0/xx unknown
- 2002-06-07 IL IL16194602A patent/IL161946A0/xx unknown
- 2002-06-07 CN CNB028242866A patent/CN100372846C/zh not_active Expired - Fee Related
- 2002-06-07 BR BR0214749-1A patent/BR0214749A/pt not_active IP Right Cessation
- 2002-06-07 EP EP02744260A patent/EP1451187A1/en not_active Withdrawn
- 2002-06-07 BR BR0214999-0A patent/BR0214999A/pt not_active IP Right Cessation
- 2002-06-07 NZ NZ532926A patent/NZ532926A/en unknown
- 2002-06-07 CN CNB028242874A patent/CN100387597C/zh not_active Expired - Fee Related
- 2002-06-07 MX MXPA04005331A patent/MXPA04005331A/es unknown
- 2002-06-07 JP JP2003551142A patent/JP2005511745A/ja active Pending
- 2002-06-07 PL PL02370738A patent/PL370738A1/xx not_active Application Discontinuation
- 2002-07-06 UA UA20040604339A patent/UA77709C2/uk unknown
- 2002-07-06 UA UA20040604342A patent/UA77710C2/uk unknown
- 2002-07-06 UA UA20040604343A patent/UA77711C2/uk unknown
2004
- 2004-06-22 NO NO20042621A patent/NO20042621L/no not_active Application Discontinuation
- 2004-06-24 NO NO20042661A patent/NO20042661L/no not_active Application Discontinuation
- 2004-06-29 NO NO20042755A patent/NO20042755L/no not_active Application Discontinuation
- 2004-07-05 ZA ZA200405336A patent/ZA200405336B/en unknown
- 2004-07-05 ZA ZA200405334A patent/ZA200405334B/en unknown
- 2004-07-05 ZA ZA200405337A patent/ZA200405337B/en unknown

Also Published As

Publication number	Publication date
NZ532926A (en)	2006-06-30
WO2003050119A3 (en)	2003-07-10
WO2003050117A1 (en)	2003-06-19
RU2004117159A (ru)	2006-01-10
AU2002315006A1 (en)	2003-06-23
CA2468164A1 (en)	2003-06-19
NZ532927A (en)	2006-06-30
HRP20040503A2 (en)	2004-12-31
MXPA04005412A (es)	2004-10-11
AU2002312414B2 (en)	2009-02-19
AU2002345615A1 (en)	2003-06-23
NO20042621L (no)	2004-06-22
HRP20040504A2 (en)	2004-12-31
RU2004117156A (ru)	2006-01-10
CA2468174A1 (en)	2003-06-19
ZA200405334B (en)	2006-12-27
MXPA04005363A (es)	2004-09-27
MXPA04005331A (es)	2004-09-13
BR0214749A (pt)	2004-08-31
WO2003050119A2 (en)	2003-06-19
CN100372846C (zh)	2008-03-05
UA77709C2 (en)	2007-01-15
ZA200405336B (en)	2006-12-27
KR20040105696A (ko)	2004-12-16
JP2005511745A (ja)	2005-04-28
EP1451187A1 (en)	2004-09-01
UA77711C2 (en)	2007-01-15
US20020107262A1 (en)	2002-08-08
JP2005511746A (ja)	2005-04-28
RU2004117161A (ru)	2005-05-10
JP2005513052A (ja)	2005-05-12
EP1453829A1 (en)	2004-09-08
AU2002315006B2 (en)	2009-01-29
PL374260A1 (en)	2005-10-03
ZA200405337B (en)	2006-12-27
AU2002312414A1 (en)	2003-06-23
BR0214752A (pt)	2005-08-02
AU2002345615B2 (en)	2009-01-15
IL161945A0 (en)	2005-11-20
NZ532770A (en)	2006-07-28
CN100402528C (zh)	2008-07-16
CN1599738A (zh)	2005-03-23
PL370702A1 (en)	2005-05-30
IL161787A0 (en)	2005-11-20
WO2003050118A1 (en)	2003-06-19
CN1599739A (zh)	2005-03-23
KR20040105694A (ko)	2004-12-16
CA2468659A1 (en)	2003-06-19
EP1451186A2 (en)	2004-09-01
KR20040105695A (ko)	2004-12-16
HRP20040506A2 (en)	2004-12-31
CN101220028A (zh)	2008-07-16
CN100387597C (zh)	2008-05-14
BR0214999A (pt)	2004-12-28
NO20042661L (no)	2004-06-24
PL370738A1 (en)	2005-05-30
UA77710C2 (en)	2007-01-15
NO20042755L (no)	2004-06-29
CN1599740A (zh)	2005-03-23

Publication	Publication Date	Title
IL161946A0 (en)	2005-11-20	Urea substituted imidazopyridines
IL159445A0 (en)	2004-06-01	Azaindoles
AU2002358700A8 (en)	2003-07-15	Urea derivatives as vr1- antagonists
AU3954702A (en)	2002-06-18	Substituted imidazopyridines
SI1671949T1 (sl)	2008-10-31	Substituirani pridinilamini
ZA200309522B (en)	2005-02-23	Substituted cyclohexane-1-4diamine derivatives
IL160701A0 (en)	2004-08-31	3-substituted-4-pyrimidone derivatives
GB0130669D0 (en)	2002-02-06	Structural component
HUP0303449A3 (en)	2005-02-28	Substituted benzofuran-2-carboxamides derivatives
PL362643A1 (en)	2004-11-02	Substituted fluoroalcoxyphenylsulfonylurea
HUP0401949A3 (en)	2009-07-28	4-imidazolin-2-one derivatives
HUP0303186A3 (en)	2007-06-28	4-aminobenzopyran derivatives
GB0102146D0 (en)	2001-03-14	Attachment means
HUP0500026A3 (en)	2008-02-28	N-heteroarylnicotinamide derivatives
PT1406858E (pt)	2009-09-21	4-aminociclo-hexanóis substituídos
EP1364954A4 (en)	2009-10-28	Dicarba closo DODECARBORANDERIVATE
PL364601A1 (en)	2004-12-13	Substituted benzo-nitro-heterocycles
EG23586A (en)	2006-09-13	Haemagel solution
CA92743S (en)	2001-06-26	Stopwatch
CA92740S (en)	2001-06-29	Stopwatch
CA92631S (en)	2001-06-15	Stopwatch
CA92741S (en)	2001-06-29	Stopwatch
CA92744S (en)	2001-06-29	Stopwatch
CA92742S (en)	2001-06-29	Stopwatch
CA92738S (en)	2001-06-29	Stopwatch